Matthew Stober Joins the Board of GeminiBio
In a significant development for the biopharma industry, Matthew Stober has been appointed to the Board of Directors at Gemini Bioproducts, LLC, also known as GeminiBio. This partnership is expected to bring valuable expertise from Stober, positioned to enhance the company's strategic initiatives.
An Overview of GeminiBio
GeminiBio is a dedicated supplier of advanced therapy raw materials, focusing on the burgeoning fields of biopharma and cell therapies. With a robust portfolio that includes serum, customized media, buffers, and process liquids, the company directly supports the innovative research and manufacturing processes that are crucial for advancements in areas like mRNA and monoclonal antibody technologies.
The Role of Stober in Driving Innovation
Matthew Stober's extensive industry experience makes him an invaluable asset to the GeminiBio board. His background includes senior roles in large pharmaceutical companies such as Novartis, Merck, Pfizer, and GlaxoSmithKline, where he honed his operational expertise. Currently, he serves as CEO of Abzena, a contract development and manufacturing organization (CDMO), guiding the production processes from research all the way to commercial manufacturing.
Enhancing Customer Insights in Biologics Manufacturing
Stober's appointment is expected to offer GeminiBio insights into optimizing biologics manufacturing workflows. As the company seeks to facilitate improved collaboration between suppliers and biopharma manufacturers, his knowledge will be pivotal. According to Cory Stevenson, Executive Chairman of the GeminiBio board, Stober's insights will be crucial in driving growth and expanding market presence.
The Importance of Supplier Relationships
Stober emphasized the importance of robust partnerships in the biopharma and gene therapy industries, highlighting how suppliers like GeminiBio are fundamental to ensuring production efficiencies. He stated, "It is crucial that we collaborate to help deliver life-saving therapeutics to people when they need them at a price they can afford." This commitment underlines the industry's reliance on effective supply chain dynamics and the shared goals between suppliers and manufacturers.
Stober’s Additional Roles
In addition to his responsibilities at GeminiBio, Matthew Stober serves on the boards of Leiters Health, Istari Oncology, and CastleVax. His wide-ranging involvement across various organizations showcases his dedication to advancing the life sciences and therapeutic markets.
About GeminiBio and Its Operations
Founded in 1985, GeminiBio's mission revolves around streamlining workflow processes for the global biopharma, cell, and gene therapy sectors. The company aims to accelerate the development of life-enhancing biotherapeutics, supporting customers from initial research phases to large-scale production.
GeminiBio operates from a 57,000 square foot facility located in West Sacramento, California, which is classified as FDA-registered Class 1 Medical Device Manufacturer and ISO 13485:2016 certified. This allows them to provide high-quality raw materials essential for various therapeutic manufacturing processes.
About BelHealth Investment Partners
BelHealth Investment Partners, the parent company of GeminiBio, is a healthcare-focused private equity firm based in Fort Lauderdale. It specializes in acquiring majority interests in lower middle-market companies that show potential for growth and improvement through strategic investment and management interventions.
Frequently Asked Questions
What is the role of Matthew Stober at GeminiBio?
Matthew Stober has been appointed to the Board of Directors, where he will provide insights into improving biologics manufacturing workflows.
What types of products does GeminiBio supply?
GeminiBio supplies serum, customized media, buffers, and process liquids for biopharma and advanced therapy companies.
Where is GeminiBio located?
GeminiBio is based in West Sacramento, California, with a manufacturing space dedicated to the production of raw materials.
What industries does GeminiBio serve?
GeminiBio serves the biopharma, cell and gene therapy industries, focusing on the research and production of biotherapeutics.
Who are some key leaders at GeminiBio?
In addition to Matthew Stober, the board includes Cory Stevenson, the Executive Chairman, and Brian Parker, the CEO.
